<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03191500</url>
  </required_header>
  <id_info>
    <org_study_id>LT002</org_study_id>
    <nct_id>NCT03191500</nct_id>
  </id_info>
  <brief_title>Evaluate the Safety and Efficacy of a Steerable Catheter in the Treatment of Vascular Interventional Access</brief_title>
  <official_title>Evaluate the Safety and Efficacy of a Steerable Catheter in the Treatment of Vascular Interventional Access : a Prospective, Muti-center, Single-arm Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hangzhou Wei Qiang Medical Technology Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hangzhou Wei Qiang Medical Technology Co., Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multicenter, single-arm clinical trial to evaluate safety and efficacy
      of a steerable catheter in the establishment of vascular intervention access. five centers
      participate in this study. The total enrollment number is 68. In the procedure of vascular
      interventional surgery or angiography diagnosis, the steerable catheter are used to building
      vascular interventional access. Evaluate the safety and efficacy of the product, by the
      observation and record the relative index of subjects intraoperative and postoperative
      (discharge) before and after 30 days .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multicenter, single-arm clinical trial to evaluate safety and efficacy
      of a steerable catheter in the establishment of vascular intervention access. five centers
      participate in this study. The total enrollment number is 68. In the procedure of vascular
      interventional surgery or angiography diagnosis, the steerable catheter are used to building
      vascular interventional access. Evaluate the safety and efficacy of the product, by the
      observation and record the relative index(like catheter compliance, catheter directivity, and
      catheter visibility under X ray) of subjects in the procedure, telephone follow up at 30 days
      investigate the subjects healthy condition.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 11, 2017</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">November 27, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>procedure success rate</measure>
    <time_frame>during the procedure</time_frame>
    <description>The procedure success rate should fulfill the following three point at the same time:1 the steerable catheter can assist the guiding wire into the target vascular. 2 the steerable catheter can follow the guiding wire into the target vascular. 3 the steerable catheter can remove from the subject successfully.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the steerable catheter compliance during the procedure of catheter access into the target vascular</measure>
    <time_frame>during the procedure</time_frame>
    <description>evaluate with excellent, good , general, poor four levels (according to surgeons experience to score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the steerable catheter directivity during the procedure of catheter access into the target vascular</measure>
    <time_frame>during the procedure</time_frame>
    <description>evaluate with excellent, good , general, poor four levels (according to surgeons experience to score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the steerable catheter visibility under the X-ray during the procedure of catheter access into the target vascular</measure>
    <time_frame>during the procedure</time_frame>
    <description>evaluate with excellent, good , general, poor four levels (according to surgeons experience to score)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Peripheral Vascular Diseases</condition>
  <arm_group>
    <arm_group_label>steerable catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>to study the safety and efficacy of a steerable catheter in the treatment of peripheral vascular disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>steerable catheter</intervention_name>
    <description>peripheral vascular disease</description>
    <arm_group_label>steerable catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age from 18 to 80, male or female.

          -  Complying with the standard of peripheral vascular interventional operation treatment
             , complying with the standard treatment of vascular angiogram, need to establish
             vascular interventional treatment access.

          -  The subject who is able to understand the test purpose, voluntarily join this clinical
             trial with informed consent forms.

        Exclusion Criteria:

          -  Patients with cerebrovascular accident or major gastrointestinal bleeding in six
             months unable to carry out antithrombotic therapy because of having contraindications
             to antiplatelet agents and anticoagulants and have haemorrhage tendency

          -  Hypohepatia, hematuria, deep vein thrombosis, and/or receiving the immunosuppressant
             therapy

          -  The distal target vessel blood flow low may produce thrombosis

          -  The women who pregnancy, lactation and can't contraception during the trial period

          -  Patients has been involved in other drugs or medical devices clinical trials related
             to treatment of the target lesion or has been involved in other drugs or medical
             device clinical trials but have not reached the primary endpoint of the study

          -  Patients unable or unwilling to participate in this trial

          -  the researcher determine the patient is not suitable to participate in clinical
             research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weiguo Fu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fudan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zhongshan hospital Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2017</study_first_submitted>
  <study_first_submitted_qc>June 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2017</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

